Natco Pharma gets EIR from USFDA for Kothur’s formulation facility

25 Apr 2020 Evaluate
Natco Pharma has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the pre-approval inspection conducted at its drug formulations facility in Kothur village, Telangana, India, during the period from March 2nd to March 6th, 2020.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

917.90 3.05 (0.33%)
19-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.10
Dr. Reddys Lab 1278.90
Cipla 1517.00
Zydus Lifesciences 919.85
Lupin 2125.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×